Published in Trop Med Parasitol on December 01, 1988
Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol (1995) 1.20
Cytokines and adhesion molecules expression in the brain in human cerebral malaria. Int J Environ Res Public Health (2005) 1.00
Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity? Fluids Barriers CNS (2014) 0.84
Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol Biochem Parasitol (2001) 3.49
Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice. Infect Immun (1993) 2.25
Nitric oxide in cerebral malaria. J Infect Dis (1994) 1.64
Can Babesia infections be used as a model for cerebral malaria? Parasitol Today (1999) 1.53
Histological study of the internal mammary artery with emphasis on its suitability as a coronary artery bypass graft. Ann Thorac Surg (1993) 1.48
Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data. Parasitology (2005) 1.44
Murine malaria. IV. Disturbed immunological responsiveness during Plasmodium berghei infection. Exp Parasitol (1971) 1.28
Interactions between gut-associated lymphoid tissue and colonization levels of indigenous, segmented, filamentous bacteria in the small intestine of mice. Can J Microbiol (1998) 1.22
Oxidative stress in malaria; implications for prevention and therapy. Pharm World Sci (1996) 1.22
Comparative anatomic studies of various arterial conduits for myocardial revascularization. J Thorac Cardiovasc Surg (1990) 1.17
Immunological aspects of cerebral lesions in murine malaria. Clin Exp Immunol (1989) 1.16
Plasmodium berghei ANKA: purification of large numbers of infectious gametocytes. Exp Parasitol (1998) 1.15
Whole-body inflammation in trauma patients. An autopsy study. Arch Surg (1988) 1.14
Malaria chemosuppression in pregnancy. III. Its effects on the maternal malaria immunity. Trop Geogr Med (1993) 1.09
Plasmodium berghei: recombinant interferon-gamma and the development of parasitemia and cerebral lesions in malaria-infected mice. Exp Parasitol (1993) 1.07
Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum. J Biol Chem (2001) 1.04
Pregnancy associated recrudescence in murine malaria (Plasmodium berghei). Tropenmed Parasitol (1980) 1.02
Low dosages of interleukin 1 protect mice against lethal cerebral malaria. J Exp Med (1990) 1.01
Convulsions due to increased permeability of the blood-brain barrier in experimental cerebral malaria can be prevented by splenectomy or anti-T cell treatment. J Infect Dis (1998) 1.00
Morphological characteristics of intracerebral arterioles in clinical (Plasmodium falciparum) and experimental (Plasmodium berghei) cerebral malaria. J Neurol Sci (1991) 1.00
Leukocytes in a Plasmodium falciparum-infected blood meal reduce transmission of malaria to Anopheles mosquitoes. Infect Immun (1997) 0.99
Depressed malarial immunity in pregnant mice. Infect Immun (1980) 0.97
Hypertrophic cardiomyopathy associated with a mitochondrial myopathy of voluntary muscles and congenital cataract. Br Heart J (1985) 0.97
In vitro development of infectious liver stages of P. yoelii and P. berghei malaria in human cell lines. Exp Parasitol (1994) 0.96
Autopsy analysis in surgical patients: a basis for clinical audit. Br J Surg (1992) 0.95
Dietary fish-oil supplementation in experimental gram-negative infection and in cerebral malaria in mice. J Infect Dis (1992) 0.94
Chylopericardium and chylothorax, resulting from a catheter to the left subclavian vein: an autopsy report. Klin Wochenschr (1989) 0.94
Variability of intercapillary distance estimated on histological sections of rat heart. Adv Exp Med Biol (1985) 0.92
Endomyocardial lesion and endomyocardial fibrosis in experimental malaria (Plasmodium berghei) in mice. Contrib Microbiol Immunol (1983) 0.91
Immunization against cerebral pathology in Plasmodium berghei-infected mice. Parasitology (1992) 0.91
Separation of parasitized erythrocytes from Plasmodium berghei infected mouse blood. Trans R Soc Trop Med Hyg (1977) 0.90
Cortisol and Plasmodium falciparum infection in pregnant women in Kenya. Trans R Soc Trop Med Hyg (1990) 0.89
Malaria immunity and premunition in a Plasmodium berghei mouse model. Isr J Med Sci (1978) 0.89
Circulating tumour necrosis factor alpha is not involved in the development of cerebral malaria in Plasmodium berghei-infected C57Bl mice. Parasite Immunol (1997) 0.88
Quality control in fatally injured patients: the value of the necropsy. Eur J Surg (1993) 0.88
Cortisol and loss of malaria immunity in human pregnancy. Br J Obstet Gynaecol (1987) 0.87
Chronic, patent Plasmodium berghei malaria in splenectomized mice. Infect Immun (1982) 0.87
Plasmodium berghei: effect of antithymocyte serum on induction of immunity in the mouse. Exp Parasitol (1979) 0.87
Ultrastructural changes in the blood-brain barrier of mice infected with Plasmodium berghei. Acta Leiden (1992) 0.87
Chloroquine containing liposomes in the chemotherapy of murine malaria. Parasitology (1989) 0.86
Tumour necrosis factor-alpha and macrophages in Plasmodium berghei-induced cerebral malaria. Parasitology (1993) 0.86
Immunological properties of recombinant proteins of the transmission blocking vaccine candidate, Pfs48/45, of the human malaria parasite Plasmodium falciparum produced in Escherichia coli. Parasite Immunol (1998) 0.85
Effects of interleukin-8 on nonspecific resistance to infection in neutropenic and normal mice. Antimicrob Agents Chemother (1993) 0.85
Features of a syndrome with congenital cataract and hypertrophic cardiomyopathy. Am J Ophthalmol (1986) 0.85
Role of macrophages in the pathogenesis of endomyocardial fibrosis in murine malaria. Trans R Soc Trop Med Hyg (1984) 0.84
Role of spleen in morbidity and mortality of Plasmodium berghei infection in mice. Infect Immun (1980) 0.84
Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice. Infect Immun (1994) 0.84
Dietary n-3 fatty acids increase spleen size and postendotoxin circulating TNF in mice; role of macrophages, macrophage precursors, and colony-stimulating factor-1. J Immunol (1996) 0.84
Plasmodium berghei: premunition, sterile immunity, and loss of immunity in mice. Exp Parasitol (1980) 0.84
The results of autopsy of patients with surgical diseases of the digestive tract. Surg Gynecol Obstet (1992) 0.83
Plasmodium berghei: a mouse model for the "sudden death" and "malarial lung" syndromes. Exp Parasitol (1983) 0.83
Therapeutic effect of chloroquine(CQ)-containing immunoliposomes in rats infected with Plasmodium berghei parasitized mouse red blood cells: comparison with combinations of antibodies and CQ or liposomal CQ. Biochim Biophys Acta (1989) 0.82
Growth pattern of tumor xenografts in Wistar rats after treatment with cyclophosphamide, total lymphoid irradiation and/or cyclosporin A. Int J Radiat Oncol Biol Phys (1983) 0.82
Inferior epigastric artery as a free graft for myocardial revascularization. J Thorac Cardiovasc Surg (1991) 0.82
Induction of Plasmodium falciparum sporozoite-neutralizing antibodies upon vaccination with recombinant Pfs16 vaccinia virus and/or recombinant Pfs16 protein produced in yeast. Mol Biochem Parasitol (1995) 0.82
Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice. J Pharmacol Exp Ther (1999) 0.81
Selective damage of hippocampal neurons in murine cerebral malaria prevented by pentoxifylline. J Neurol Sci (1993) 0.81
Protective and pathological activity in serum of mice developing resistance to Plasmodium berghei infection. Parasite Immunol (1989) 0.81
A cytochemical study of cerebrovascular lesions in mice infected with Plasmodium berghei. J Neurol Sci (1991) 0.80
Plasmodium vinckei: optimization of desferrioxamine B delivery in the treatment of murine malaria. Exp Parasitol (1998) 0.80
Tissue reaction after intramuscular injection of liposomes in mice. Int J Clin Pharmacol Ther Toxicol (1992) 0.80
Cortisol levels in human pregnancy in relation to parity and age. Am J Obstet Gynecol (1986) 0.80
Repair of sublethal damage in two human tumor cell lines grown as multicellular spheroids. Int J Radiat Oncol Biol Phys (1989) 0.80
Pregnancy-induced recrudescences strengthen malarial immunity in mice infected with Plasmodium berghei. Parasitology (1985) 0.80
Plasmodium berghei: reduction of the mouse's specific lymphoproliferative response in relation to corticosterone and pregnancy. Exp Parasitol (1986) 0.79
Malaria chemosuppression during pregnancy. IV. Its effects on the newborn's passive malaria immunity. Trop Geogr Med (1993) 0.79
Plasmodium falciparum: ribosomal P2 protein gene expression is independent of the developmentally regulated rRNAs. Exp Parasitol (1998) 0.79
The parenteral controlled release of liposome encapsulated chloroquine in mice. J Pharm Pharmacol (1990) 0.79
Is malaria involved in the pathogenesis of tropical endomyocardial fibrosis? Acta Leiden (1988) 0.79
Myosin A expressions in sporogonic stages of Plasmodium. Mol Biochem Parasitol (2000) 0.78
Alcohol-induced liver injury after jejunoileal bypass operation in rats. J Hepatol (1987) 0.78
The usefulness of an endomyocardial biopsy in heart disease of unknown etiology. Int J Cardiol (1986) 0.78
Radiosensitivity of different human tumor cells lines grown as multicellular spheroids determined from growth curves and survival data. Int J Radiat Oncol Biol Phys (1989) 0.78
[Primary carcinoid of the middle ear. A case report with reference to light and electron microscopy findings]. HNO (1984) 0.78
Corticosterone regulation of the effector function of malarial immunity during pregnancy. Infect Immun (1982) 0.78
Malaria chemosuppression in pregnancy. V. Placenta malarial changes among three different prophylaxis groups. Trop Geogr Med (1993) 0.77
Stage-specific proteins of Plasmodium berghei-infected red blood cells detected by antibodies of immune mouse serum. Parasitol Res (1988) 0.77
Interleukin-1 (IL-1)-induced resistance to bacterial infection: role of the type I IL-1 receptor. Antimicrob Agents Chemother (1995) 0.77
Whole body inflammation in trauma patients; an autopsy study. Prog Clin Biol Res (1987) 0.77
Malarial immunity in pregnant mice, in relation to total and unbound plasma corticosterone. Bull Soc Pathol Exot Filiales (1983) 0.77
Tumor xenotransplantation in Wistar rats after treatment with cyclophosphamide and total lymphoid irradiation. Radiology (1982) 0.77
Attenuation of malaria infection, paralysis and lesions in the central nervous system by low protein diets in rats. Acta Trop (1992) 0.77
Immune phagocytosis of Plasmodium berghei parasites by mononuclear phagocytes. Cell Biol Int Rep (1983) 0.77
Hereditary mitochondrial hypertrophic cardiomyopathy with mitochondrial myopathy of skeletal muscle, congenital cataract and lactic acidosis. Virchows Arch A Pathol Anat Histopathol (1987) 0.76
Impaired immune responsiveness in Plasmodium berghei immune mice. Parasite Immunol (1989) 0.76
Improved myocardial capillarisation in spontaneously hypertensive rats treated with nifedipine. Cardiovasc Res (1987) 0.76
Interleukin-1 as a possible agent for treatment of infection. Eur J Clin Microbiol Infect Dis (1993) 0.76
Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice. Antimicrob Agents Chemother (1999) 0.76
Relationship of the CD22 immunotoxin dose and the tumour establishment in a SCID mice model. Leuk Lymphoma (2000) 0.76
Small bowel transplantation in the rat: the adverse effect of increased pressure during the flushing procedure of the graft. J Surg Res (1984) 0.76
Activated macrophages: inductors of endocard lesions in murine malaria. Cell Biol Int Rep (1983) 0.76
Oxygen tensions in two human tumor cell lines grown and irradiated as multicellular spheroids. Anticancer Res (1991) 0.76